Mesa Laboratories Valuation

MLAB Stock  USD 125.14  1.64  1.33%   
At this time, the firm appears to be overvalued. Mesa Laboratories secures a last-minute Real Value of $116.68 per share. The latest price of the firm is $125.14. Our model forecasts the value of Mesa Laboratories from analyzing the firm fundamentals such as Profit Margin of (1.05) %, return on equity of -0.89, and Current Valuation of 851.71 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mesa Laboratories' valuation include:
Price Book
4.3493
Enterprise Value
851.7 M
Enterprise Value Ebitda
305.6549
Price Sales
2.8225
Forward PE
35.2113
Overvalued
Today
125.14
Please note that Mesa Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Mesa Laboratories is based on 3 months time horizon. Increasing Mesa Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mesa Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mesa Stock. However, Mesa Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  125.14 Real  116.68 Target  133.33 Hype  123.87 Naive  125.78
The real value of Mesa Stock, also known as its intrinsic value, is the underlying worth of Mesa Laboratories Company, which is reflected in its stock price. It is based on Mesa Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mesa Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
113.80
Downside
116.68
Real Value
135.85
Upside
Estimating the potential upside or downside of Mesa Laboratories helps investors to forecast how Mesa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mesa Laboratories more accurately as focusing exclusively on Mesa Laboratories' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
1.761.811.86
Details
Hype
Prediction
LowEstimatedHigh
120.99123.87126.75
Details
Potential
Annual Dividend
LowForecastedHigh
0.370.370.38
Details
4 Analysts
Consensus
LowTarget PriceHigh
121.33133.33148.00
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mesa Laboratories' intrinsic value based on its ongoing forecasts of Mesa Laboratories' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mesa Laboratories' closest peers. If more than one evaluation category is relevant for Mesa Laboratories we suggest using both methods to arrive at a better estimate.

Mesa Laboratories Cash

17.34 Million

Mesa Valuation Trend

Comparing Mesa Laboratories' enterprise value against its market capitalization is a good way to estimate the value of Mesa Laboratories uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.

Mesa Laboratories Total Value Analysis

Mesa Laboratories is now forecasted to have valuation of 851.71 M with market capitalization of 671.05 M, debt of 231.3 M, and cash on hands of 43.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mesa Laboratories fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
851.71 M
671.05 M
231.3 M
43.75 M

Mesa Laboratories Investor Information

About 96.0% of the company shares are owned by institutional investors. The book value of Mesa Laboratories was now reported as 28.57. The company has Price/Earnings (P/E) ratio of 433.94. Mesa Laboratories recorded a loss per share of 46.32. The entity last dividend was issued on the 28th of February 2025. Based on the key indicators related to Mesa Laboratories' liquidity, profitability, solvency, and operating efficiency, Mesa Laboratories is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities53.3 M50.8 M
Sufficiently Up
Slightly volatile

Mesa Laboratories Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mesa Laboratories has an asset utilization ratio of 48.39 percent. This suggests that the Company is making $0.48 for each dollar of assets. An increasing asset utilization means that Mesa Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Mesa Laboratories Ownership Allocation

The market capitalization of Mesa Laboratories is $671.05 Million. The majority of Mesa Laboratories outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mesa Laboratories to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mesa Laboratories. Please pay attention to any change in the institutional holdings of Mesa Laboratories as this could imply that something significant has changed or is about to change at the company. Also note that almost eighty-nine thousand one hundred eleven invesors are currently shorting Mesa Laboratories expressing very little confidence in its future performance.

Mesa Laboratories Profitability Analysis

The company reported the previous year's revenue of 216.19 M. Net Loss for the year was (254.25 M) with profit before overhead, payroll, taxes, and interest of 151.48 M.

Mesa Laboratories Past Distributions to stockholders

Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mesa Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mesa Laboratories and how it compares across the competition.

About Mesa Laboratories Valuation

The stock valuation mechanism determines Mesa Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Mesa Laboratories. We calculate exposure to Mesa Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mesa Laboratories's related companies.
Last ReportedProjected for Next Year
Gross Profit153.2 M160.9 M
Pretax Profit Margin(1.47)(1.39)
Operating Profit Margin(1.45)(1.37)
Net Loss(1.35)(1.28)
Gross Profit Margin 0.71  0.69 
Mesa Laboratories' stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Mesa Laboratories' value is low or high relative to the company's performance and growth projections. Determining the market value of Mesa Laboratories can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Mesa Laboratories represents a small ownership stake in the entity. As a stockholder of Mesa, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Mesa Laboratories Dividends Analysis For Valuation

As of March 21, 2025, Dividends Paid is expected to decline to about 2.3 M. In addition to that, Dividend Yield is expected to decline to 0.01. The current year's Price Earnings To Growth Ratio is expected to grow to 0.0001, whereas Retained Earnings are projected to grow to (200.5 M).
Last ReportedProjected for Next Year
Dividends PaidM2.3 M
Dividend Yield 0.01  0.01 
Dividend Payout Ratio(0.01)(0.01)
Dividend Paid And Capex Coverage Ratio 8.44  7.96 
There are various types of dividends Mesa Laboratories can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Mesa shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Mesa Laboratories directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Mesa pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Mesa Laboratories by the value of the dividends paid out.

Mesa Laboratories Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding5.4 M
Quarterly Earnings Growth Y O Y3.875
Forward Price Earnings35.2113

Mesa Laboratories Current Valuation Indicators

Valuation refers to the process of determining the present value of Mesa Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mesa we look at many different elements of the entity such as Mesa's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mesa Laboratories, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mesa Laboratories' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mesa Laboratories' worth.

Complementary Tools for Mesa Stock analysis

When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges